Raltitrexed in Treating Children With Refractory Acute Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of raltitrexed in treating children with refractory
acute leukemia. Drugs used in chemotherapy use different ways to stop tumor cells from
dividing so they stop growing or die